Deep Intelligence Across Industries

Health Catalyst, Inc. is a healthcare data-and-analytics technology and services company headquartered in the Salt Lake City metropolitan area. It was incorporated in Delaware in September 2011 under the name HQC Holdings, Inc., and adopted its current name in March 2017, though the operating business traces to 2008 — a lineage the current CEO references directly, describing "eighteen years working with health systems" on the Q2 2026 earnings call (Q2 2026 earnings release, 6 Aug 2026). The company completed its initial public offering in July 2019. **Positioning statement (150 words).** Health Catalyst occupies the healthcare-specific layer of the provider data stack: it ingests, normalises and governs clinical, claims, financial and operational data for health systems, then sells analytics applications and human expertise on top of it. Its distinctive asset is not infrastructure — management now openly concedes the data-platform layer has commoditised against Databricks, Snowflake and Microsoft — but a proprietary corpus of measured improvement outcomes accumulated over 18 years and more than 2,000 documented, client-verified improvements. The 2026 strategy under new CEO Ben Albert reframes the company as a "healthcare intelligence" business: an AI-enabled improvement layer that quantifies, prioritises and sequences cost, clinical-quality, ambulatory-growth and consumer interventions. Execution risk is acute. The company is simultaneously migrating clients off its legacy DOS platform, restructuring its cost base, having divested its most profitable software unit, and carrying an accumulated deficit above USD 1.5 billion against a market capitalisation near USD 135 million. --- ### 2.1 The company's own description The FY2025 Form 10-K opens with an unchanged framing: *"We are a leading provider of data and analytics technology and services to healthcare organizations. Our Solution comprises our cloud-based data and analytics platform, software applications, and expertise. Our clients, which are primarily healthcare providers, use our Solution to manage their data, derive analytical insights to operate their organization, and produce measurable clinical, financial, and operational improvements. We envision a future where all healthcare decisions are data-informed."* The company organises its self-description around three components: (i) the Ignite Data & Analytics Platform, a healthcare-specific, cloud-based, open and self-service ecosystem for analytics, application development and interoperability; (ii) Applications, software analytics products built on Ignite across five focus areas — Clinical Improvement, Revenue & Cost Improvement, Ambulatory Operations, Measures & Registries, and Data & Analytics; and (iii) Expertise, a services organisation of data engineers, data scientists, clinicians and healthcare administrators delivering implementation, analytics, abstraction, cost-accounting and Tech-Enabled Managed Services (TEMS). The company describes its operating philosophy through the "Health Catalyst Flywheel": team-member engagement drives quality of work, which drives measurable client improvement, which drives client trust, renewal, expansion and referral, which drives predictable financial performance. This construct is not decorative — it is referenced in the executive compensation design disclosed in the 10-K/A, where annual bonus outcomes for all team members are tied to client outcomes, growth and Adjusted EBITDA. By August 2026 the company's boilerplate had been rewritten materially. The Q2 2026 release describes Health Catalyst as *"a healthcare intelligence company designed to accelerate measurable improvement for health systems across cost, clinical, and consumer performance,"* backed by *"deep domain expertise, proprietary AI-driven technology, and $2.8 billion in documented outcomes."* The shift from "data and analytics technology and services" to "healthcare intelligence" is the clearest single marker of the strategy reset. ### 2.2 Independent characterisation Health Catalyst is, in economic terms, a hybrid of three businesses that have historically been bundled and are now being deliberately unbundled. The first is a healthcare data-platform business (formerly DOS, now Ignite) sold on multi-year subscription. This is the anchor relationship: it creates switching costs, it is the surface on which applications are sold, and it is the layer under most competitive pressure. Management's Q1 2026 admission that "healthcare data infrastructure has increasingly commoditized" is a significant concession from a company whose original thesis was that healthcare data warehousing required purpose-built architecture. The second is a portfolio of point-solution applications, largely assembled through twelve acquisitions since 2018 — patient engagement (Twistle, Upfront), care orchestration (Lumeon), oncology (Carevive), registries (ARMUS, CRStar/ERS), measures (MeasureAble/Able Health), cost accounting (PowerCosting), labour management (PowerLabor), interoperability (Ninja Universe/KPI Ninja), cybersecurity (Intraprise), and — until 31 July 2026 — mid-revenue-cycle (Vitalware). These applications carry higher gross margins than services and are the intended vehicle for AI monetisation. The third is a professional services and managed-services organisation. This is the structurally problematic segment: FY2025 adjusted gross margin of 18.3% and GAAP gross margin of 12.8%, on revenue that declined 8% year over year. Management now guides this business to roughly USD 55 million annually exiting 2026, versus USD 111.7 million in FY2024 — a deliberate contraction of nearly half. **Revenue model mix.** The company reports two revenue lines only: Technology revenue is predominantly recurring subscription; professional services is a mix of recurring managed services (TEMS) and project-based, non-recurring engagement revenue. The company explicitly flags fluctuation in "project-based, non-recurring revenue" as a principal risk in every earnings release reviewed. **Value-chain position.** Health Catalyst sits between the EHR system of record (Epic, Oracle Health) and the health system's executive decision-making layer. It does not own the transactional workflow; it owns the analytic abstraction of it. This is simultaneously its defensibility (EHR vendors historically underinvested in cross-source analytics) and its vulnerability (EHR vendors are now investing heavily, and the 10-K names "the increasing market share of EHR companies in data analytic services, patient engagement and other parts of our Solution" as a specific cause of contract termination risk). **Customer types and end-markets.** Academic medical centres, integrated delivery networks, community hospitals, large physician practices, Accountable Care Organizations, health information exchanges, health insurers, life-science organisations, healthcare technology vendors (for cybersecurity) and other risk-bearing entities. Named clients in the FY2025 10-K: Allina Health, AlohaCare, Baylor Scott & White Health, Carle Health, Children's Hospital of Orange County, Community Health Network, Contexture, INTEGRIS Health, Lifepoint Health, Mass General Brigham, MultiCare, Queen's Health System, Temple University Health System, UnityPoint Health, UPMC. No client represented more than 10% of total revenue in FY2025, FY2024 or FY2023 (10-K FY2025). ---

Company Headquarters: New York, US Founded: 1999 Workforce: ~40,000 Company Working: ExlService Holdings Inc (ExlService) is a business process management service provider. The company offers domain expertise, operations management, data analytics, digital technology platforms, and various services such as insurance, healthcare, and banking solutions. It also provides financial, travel, transportation, and logistics solutions, finance and accounting solutions, consulting services, analytics solutions, and digital solutions. It serves the insurance, healthcare, travel and leisure, transportation and logistics, banking and financial, and utility industries. It has a business presence in the US, Europe, Latin America, South Africa, Australia, and Asia.

Company Headquarters: Illinois, US ‎ Founded: 1986 Workforce: ~8,400 Company Working: Allscripts Healthcare, LLC (Allscripts) is a leader in healthcare information technology solutions, providing advanced clinical, financial, and operational results to clients. The company offers comprehensive healthcare industry solutions designed to help clients improve the quality and efficiency of healthcare services by providing electronic health records (EHR), financial management, population health management, and precise medicine/consumer solutions. The company has a global presence across 7 countries: the US, Australia, India, Canada, Singapore, Israel, and the UK.

Company Headquarters: Selangor, Malaysia Founded: 1988 Workforce: ~3,000 Company Working: Karex Berhad is the world’s largest condom and lubricant manufacturer. The company has operations across the UK, US, Malaysia, and Thailand. It has clientele, including NGOs, governments, and brand owners, and retails in more than 130 countries across the globe. Karex Berhad has operations in the Americas, Asia, Europe, and Africa. It manufactures condoms with numerous colors, textures, and properties.

Company Headquarters: Delhi, India Founded: 1991 Workforce: ~18000 Company Working: Mankind Pharma (Mankind) is a leading pharmaceutical company. The company manufactures products for antibiotics, gastrointestinal, cardiovascular, dermal, erectile dysfunction medications, and sexual wellness. The company operates in more than 34 countries including Asia, Africa, South-East Asia, Gulf countries and CIS countries. Moreover, the company specializes in pharmaceuticals, FMCG, OTC, prescription medicine, veterinary medicine, manforce condoms, acnestar, ring-out, preganews, unwanted 72, unwanted 21 days, gas-o-fast, kabzend, and kaloree1.

Company Headquarters: Karnataka, India Founded: 1978 Workforce: ~16,545 Company Working: Biocon manufactures and sells generic active pharmaceutical ingredients (APIs). It also provides a variety of branded formulations, complex biologics, and biosimilars like monoclonal antibodies (MAbs), rh-Insulin, and insulin analogues in addition to several active pharmaceutical ingredients (APIs). Additionally, the company provides contract manufacturing, medicine licensing, research, development, and the production of both small and large molecules to pharmaceutical and biotechnology organizations all over the world. In order to develop solutions that meet the various needs of patients around the world, Biocon has invested in cutting-edge technology, major research collaborations, and global manufacturing scale over the years. As an emerging international company, Biocon is meeting patients' needs in more than 100 nations with unique products. It has a production unit and an R&D facility at BioXcell in Malaysia. Furthermore, it has operations in the UK, Ireland, the US, Switzerland, Dubai, and Malaysia.

Company Headquarters: Bridgewater, US Founded: 2011 Workforce: ~ 40,039 Company Working: Vyne Therapeutics Inc., formerly known Menlo Therapeutics, focused on the development and commercialization of serlopitant for the treatment of pruritus, or itch, associated with various conditions such as prurigo nodularis and psoriasis. It has a sales presence in the US and Israel.

Company Headquarters: Ballerup, Copenhagen, Denmark Founded: 1908 Workforce: ~5,820 Company Working: LEO Pharma A/S (LEO Pharma) is a global dermatology company. The company develops and markets products for dermatology, bone remodeling thrombosis, and coagulation. It provides products in multiple delivery systems such as topical, injections, and tablets. It operates through six major business segments, including Psoriasis, Eczema /Skin infection, Thrombosis, Acne/Rosacea, Actinic keratosis, and CMOs/Others. The company has a presence in more than 130 countries globally.

Company Headquarters: California, US Founded: 2013 Workforce: 622+ Company Working: Guardant Health (Guardant) is one of the leading precision oncology companies that is focused on helping conquer cancer globally through the use of its proprietary blood-based tests, vast data sets and advanced analytics. The company has provided its offerings to more than 5,000 oncologists, over 40 biopharmaceutical companies, and all 27 of the National Comprehensive Cancer Network centers. The company operates its business through two main geographical segments- the US and International.

Company Headquarters: Dublin, Ireland Founded: 1990 Workforce: ~38,000 Company Working: Icon plc offers a wide range of clinical development, consulting, and commercialization services across 46 countries. It provides a wide range of services, including clinical research services, commercial positioning, functional services provision, laboratories, medical imaging, real-world intelligence, and site & patient solutions. The organization has extensive experience in diverse therapeutic areas such as cardiovascular, cell, and gene therapies, central nervous system, endocrine and metabolic disorders, infectious diseases, internal medicine and immunology, oncology, and pediatrics. Moreover, it operates in markets and industry verticals such as biosimilar, biotech, government & public health solutions, and pharmaceuticals and has operational facilities across 147 locations.

Company Headquarters: Utah, US Founded: 1991 Workforce: 2,400+ Company Working: Myriad Genetics, Inc. (Myriad) is one of the first few genomics companies pioneering in molecular diagnostics. Myriad is one of the leaders in molecular diagnostics with product offerings in the therapeutic areas such as hereditary cancer, urological cancer, lung cancer, autoimmune disorders, and other diseases. In 1996, Myriad introduced the first molecular diagnostic test for hereditary breast and ovarian cancer. The test, BRACAnalysis was widely accepted and later approved by FDA for the companion diagnostics for breast cancer. The company has international headquarters located in Switzerland. Additionally, the Company has laboratories in Austin (Texas), Munich (Germany), Salt Lake City (UT), South San Francisco (CA). Myriad is present in 128 countries and serves its customers through its subsidiaries and distributors.

Company Headquarters: Saluggia, Italy Founded: 2000 Workforce: ~ 1,971 Company Working: DIASORIN S.P.A. is an Italian multinational group and a global leader in the in-vitro diagnostics market. It is one of the listed companies on MTA (Mercato Telematico Azionario) in the FTSE Italia Mid Cap Index, organized and managed by Borsa Italiana S.p.A. It provides its services to hospitals, private testing laboratories of immunodiagnostics, and molecular diagnostics. It is one of the leading healthcare companies that provide services to about 4000 US hospitals and health systems and approximately 165,000 other providers and healthcare organizations. It provides services at lower costs to hospitals and other pharmaceutical industries.

Company Headquarters: Boulder, Colorado US Founded: 2014 Workforce: 500 Company Working: Charlotte's Web Holdings Inc. is involved in the production and distribution of hemp-based, cannabidiol products. There are various products offered by the company which includes tinctures, capsules, and topical. The company distributes its products under Charlotte’s Web and CW names through an e-commerce website, wholesalers, and retailing shops. The company has 3680 retail locations for distributing its products. Earlier the company was known as Stanley Brothers Holdings Inc. and changed its name to Charlotte’s Web in July 2018.

Company Headquarters: California, US Founded: 2009 Workforce: ~50 Company Working: Medical Marijuana Inc. was the world’s first legal supplier of CBD. The company’s focus is on areas such as the development of the international CBD pipeline, the manufacturing of legal cannabis-based consumer products and drugs, and developing new markets for medical cannabis. It offers products such as hemp oils, cannabidiol drops, and tinctures for consumers. It also uses an online portal for the distribution of its products across the world.

Company Headquarters: California, US Founded: 2014 Workforce: ~30 Company Working: Isodiol International Inc. is a leader in pharmaceutical grade phytochemical compounds and an industry leader in the manufacturing and development of consumer products. The company has commercialized naturally isolated CBD with micro-encapsulation and nanotechnology to develop quality consumable and topical skincare products. It offers supplements, vitamins, pharmaceuticals, and various nutraceutical products. The company’s product range involves daily products, CBD pet products, CBD sport products, and skin care products.

Company Headquarters: Ontario, Canada Founded: 2013 Workforce: ~2,000 Company Working: Canopy Growth Corporation, a well-known Canadian company, is engaged in the production, distribution, and marketing of a wide range of cannabis and hemp-based products across the globe. The company operates through two business segments, namely, cannabis, hemp, & other consumer products and Canopy Rivers Inc. It offers renowned brands in the global market, including BioSteel, TWD, Tweed, Tokyo Smoke, First & Free, and DOJA. The firm has a strong presence in Canada, the US, Germany, the UK, Australia, Denmark, Peru, and Brazil.

Company Headquarters: Edmonton, Alberta Founded: 2013 Workforce: 201-500 Company Working: Aurora Cannabis Inc. is a renowned integrated cannabis company with an industry-leading reputation for continuously elevating and setting the global cannabis industry standard.

Company Headquarters: California, US Founded: 1948 Workforce: 6,600 Company Working: Varian Medical Systems, Inc. designs, manufactures, sells, and services medical devices and software products for treating cancer and other medical conditions worldwide. It operates through two segments, namely, oncology systems and proton solutions.

Company Headquarters: France Founded: 1974 Workforce: 134 Company Working: DMS Group specializes in high technology solutions that assist the diagnostic medical imaging community. It is involved in manufacturing and distributing imaging systems dedicated to conventional and digital radiology as well as bone densitometry. DMS Group constitutes two subsidiaries, namely, DMS and Apelem.

Company Headquarters: Japan Founded: 1946 Workforce: 1,512 Company Working: Kissei Pharmaceutical Co., Ltd (Kissei) is into research and development, manufacture, and sales of pharmaceutical products. It is also into the development and sales of therapeutic and care foods. The company has its laboratories and plants in Japan. It also has a subsidiary named Kissei America, Inc. present in New Jersey, US.

Company Headquarters: Massachusetts, US Founded: 1997 Workforce: 200 Company Working: Keryx Biopharmaceuticals, Inc. (Keryx) is the wholly owned subsidiary of Akebia Therapeutics. The merged company functions under the name of Akebia. It is into developing and delivering therapies to patients suffering from chronic kidney disease.

Company Headquarters: Waltham, Massachusetts, US Founded: 1979 Workforce: ~ 5000 Company Working: Cotiviti Holdings, Inc is a leading analytical company that focuses on improving the quality performance of clients and customers. It operates through segments such as quality improvement, risk adjustment, and network performance management programs. It also provides analytical solutions that help payers to achieve their business objectives. It serves analytical solutions to 25 payers in US healthcare. It is one of the leading providers of analytics-driven payment accuracy and management solutions worldwide. It is primarily focused on the healthcare sector.

Company Headquarters: Charlotte, US Founded: 1967 Workforce: ~ 2,200 Company Working: Premier, Inc operates majorly in health services. It operates through two segments, namely, supply chain services, and performance services. It is one of the leading healthcare companies that provide services to about 4000 US hospitals and health systems and approximately 165,000 other providers and healthcare organizations. It provides services at lower costs to hospitals and other pharmaceutical industries.

Company Headquarters: North Kansas City, Missouri, US Founded: 1979 Workforce: ~29,200 Company Working: Cerner Corporation develops, installs, and markets, various healthcare information technologies, healthcare devices, and hardware & content solutions for healthcare organizations and consumers. It also provides value-added services such as implementation and training, remote hosting, and operational management services. It mainly operates through two segments, namely, domestic and global. It currently represents its products in around 190 countries across the globe. Its development and production facilities are based in Germany, China, South Africa, Sweden, the UK, and the US.

Company Headquarters: Massachusetts, US Founded: 1960 Workforce: ~6500 Company Working: Bruker is specialized as the developer, manufacturer, and distributor of scientific instruments, analytical, and diagnostic solutions products. Bruker operates through two segments, namely Bruker Scientific Instruments and Bruker Energy & Supercon Technologies. It has technical and manufacturing centers present across Europe and North America. The company is making significant investments in R&D, to introduce innovative manufacturing p­rocesses.

Company Headquarters: Tokyo, Japan Founded: 1947 Workforce: ~744 Company Working: Seikagaku Corporation is a leading pharmaceutical and medical devices company in Japan. It operates through two business segments, namely pharmaceuticals and limulus amebocyte lysate (LAL). The pharmaceuticals segment manufactures cross-linked ophthalmic surgical aids, hyaluronate hydrogel for knee osteoarthritis, intra-articular injections for improving joint functions, and surgical aids for endoscopic mucosal resection. The LAL business segment is engaged in the production and distribution of endotoxin-detecting reagents made from LAL. The company has a pharmaceuticals manufacturing plant in Japan and endotoxin detecting manufacturing plant in the US. The Takahagi Plant owned by Seikagaku Corporation located in northern Ibaraki Prefecture (Japan) is engaged in the manufacturing of finished pharmaceutical products and medical devices. The other two production sides include Associates of Cape Cod, Inc (US) and Kurihama Plant (Japan).

Company Headquarters: Tokyo, Japan Founded: 1919 Workforce: 14,808 Company Working: Kewpie Corporation’s principal business is manufacturing, transporting, wholesaling, and warehousing food products. The company operates through different business segments, namely condiments and processed foods business, salad and delicatessen business, egg business, fruit business, fine chemical business, and distribution. It conducts extensive research and development in all the business lines. It sells its products in China and South-East Asian countries. The company invested USD 292.1 Million in its production facilities and equipment for manufacturing various chemicals and food products by the end of 2018.